AlphaStocks
6.9
Consider Buy

Solventum Corp (SOLV)

As of Sep 20, 2026, Solventum Corp (SOLV) scores 6.9/10 on AlphaStocks' five-model composite, #18 of 168 Health Care stocks.

Health Care / Health Care Technology

S&P 500

$88.89

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#18out of 168 in Health Care

Is Solventum Corp a Good Investment in 2026?

Solventum Corp (SOLV) scores 6.9 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Greenblatt Magic Formula model rates Solventum Corp as Strong (Earnings yield 12.4% · ROC >100%). However, the Lynch model rates it Caution. Solventum Corp ranks #18 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E10.0ROE31.0Market Cap16B

Valuation

Trades at 10x earnings — near sector median of 30x.

Fair value estimate not available for this stock.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

1% above fair value

Lynch

Caution

Growth rate vs price (PEG)

Greenblatt

Strong

Earnings yield 12.4% · ROC >100%

Frequently Asked Questions

Is Solventum Corp (SOLV) a good investment?
As of Sep 20, 2026, Solventum Corp (SOLV) scores 6.9/10 on AlphaStocks' five-model composite, #18 of 168 Health Care stocks. That is a middle-of-the-pack score with no strong signal either way. Trades at 10x earnings — near sector median of 30x.
What is Solventum Corp's Piotroski F-Score?
Solventum Corp's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is SOLV overvalued or undervalued?
A precise fair value estimate is not available for SOLV. Trades at 10x earnings — near sector median of 30x.
How does SOLV compare to other Health Care stocks?
Solventum Corp ranks #18 out of 168 stocks in the Health Care sector, placing it in the top 11% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about SOLV?
AlphaStocks evaluates SOLV using five proven investment models. Piotroski: Attractive; Buffett: Neutral; Graham: Caution; Lynch: Caution; Greenblatt Magic Formula: Strong. These models are combined into a single composite score of 6.9/10.

Similar Stocks

VEEVCERTDOCS

Compare SOLV with

SOLV vs VEEVCERT vs SOLVDOCS vs SOLV

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer